Back to News
Market Impact: 0.35

Warren Buffett Detailed Fundamental Analysis

LRCXBRK.ABRK.BNDAQ
Company FundamentalsAnalyst InsightsCorporate EarningsCapital Returns (Dividends / Buybacks)Technology & InnovationInvestor Sentiment & Positioning
Warren Buffett Detailed Fundamental Analysis

Validea's Patient Investor model, based on Warren Buffett's strategy, assigned Lam Research Corporation (LRCX) an 86% rating, indicating 'some interest' in the large-cap semiconductor stock. The analysis highlights LRCX's strong alignment with criteria for long-term predictable profitability and low debt, passing most fundamental tests including earnings predictability and free cash flow, though it failed on Return on Total Capital. This suggests LRCX's underlying fundamentals and valuation are favorable for a value-oriented investment approach.

Analysis

Lam Research Corporation (LRCX) has received a favorable assessment from Validea's Patient Investor model, which is based on Warren Buffett's investment principles, scoring a high 86%. This rating, which indicates 'some interest' from the strategy, suggests the large-cap semiconductor firm aligns with key criteria of long-term predictable profitability, low debt, and reasonable valuation. The company passed eight of the nine fundamental tests employed by the model, demonstrating strength in critical areas such as Earnings Predictability, Debt Service, Free Cash Flow, and Share Repurchase. The positive evaluation of its use of retained earnings and initial rate of return further underscores its financial health. The single point of weakness identified was a 'FAIL' on the Return on Total Capital metric, which warrants further scrutiny but is outweighed by the numerous positive indicators.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo